Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Lim

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
International Journal of Cancer|October 11, 2017
Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) StudyValerie Heong, Nicholas L Syn, Xiao Wen Lee, et al.
The Lancet. Oncology|January 18, 2026
Pembrolizumab plus lenvatinib in recurrent gynaecological clear cell carcinoma (LARA): a multicentre, single-arm, phase 2 trialNatalie Y L Ngoi, Jung-Yun Lee, Diana Lim, et al.
International Journal of Molecular Sciences|July 2, 2021
Targeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal AdenocarcinomaHweixian Leong Penny, Je Lin Sieow, Sin Yee Gun, et al.
Frontiers in Oncology|October 11, 2021
Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine InitiativesSneha Rajiv Jain, Wilson Sim, Cheng Han Ng, et al.
Nature Medicine|November 20, 2025
Editorial Expression of Concern: Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancerChristine M Lovly, Nerina T McDonald, Heidi Chen, et al.
Nature Medicine|September 1, 2014
Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancerChristine M Lovly, Nerina T McDonald, Heidi Chen, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
International Journal of Cancer|October 11, 2017
Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) StudyValerie Heong, Nicholas L Syn, Xiao Wen Lee, et al.
The Lancet. Oncology|January 18, 2026
Pembrolizumab plus lenvatinib in recurrent gynaecological clear cell carcinoma (LARA): a multicentre, single-arm, phase 2 trialNatalie Y L Ngoi, Jung-Yun Lee, Diana Lim, et al.
International Journal of Molecular Sciences|July 2, 2021
Targeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal AdenocarcinomaHweixian Leong Penny, Je Lin Sieow, Sin Yee Gun, et al.
Frontiers in Oncology|October 11, 2021
Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine InitiativesSneha Rajiv Jain, Wilson Sim, Cheng Han Ng, et al.
Nature Medicine|November 20, 2025
Editorial Expression of Concern: Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancerChristine M Lovly, Nerina T McDonald, Heidi Chen, et al.
Nature Medicine|September 1, 2014
Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancerChristine M Lovly, Nerina T McDonald, Heidi Chen, et al.
Pageof 6